Improving care to reduce fractures in adults with neurodevelopmental disabilities
Addressing knowledge gaps by multi-level research design to optimize clinical trial development in order to reduce fracture burden for adults with neurodevelopmental disabilities
This study is looking into the healthcare needs of adults with neurodevelopmental disabilities who are more likely to have weak bones and fractures, so we can find ways to improve their care and help them live healthier, happier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10694025 on NIH RePORTER |
What this research studies
This research investigates the healthcare needs of adults with neurodevelopmental disabilities (NDDs) who are at higher risk for bone fragility and fractures. By analyzing nationwide healthcare data, the study aims to identify risk factors for non-trauma fractures and understand the associated health burdens. The findings will help develop better clinical care strategies and optimize clinical trial designs to address these issues effectively. Ultimately, the goal is to enhance health outcomes and quality of life for this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older with neurodevelopmental disabilities who are at risk for skeletal fragility and fractures.
Not a fit: Patients without neurodevelopmental disabilities or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare strategies that significantly reduce fracture rates and enhance the overall health of adults with neurodevelopmental disabilities.
How similar studies have performed: Previous research has shown that addressing healthcare gaps in similar populations can lead to significant improvements in health outcomes, suggesting that this approach has potential for success.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hurvitz, Edward a — University of Michigan at Ann Arbor
- Study coordinator: Hurvitz, Edward a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.